JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Publisher's Correction
Right arrow Correction (v55,p800)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wong, R C W
Right arrow Articles by Adelstein, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wong, R C W
Right arrow Articles by Adelstein, S
Journal of Clinical Pathology 2002;55:488-494
© 2002 Journal of Clinical Pathology


ORIGINAL ARTICLE

A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits

R C W Wong1, R J Wilson1, R H Steele2, G Radford-Smith3, S Adelstein4

1 Division of Immunology, Queensland Health Pathology Services, Princess Alexandra and Royal Brisbane Hospitals, Brisbane, Australia
2 South Western Sydney Area Pathology Service, Liverpool Hospital Campus, Sydney, Australia
3 Department of Gastroenterology, Royal Brisbane Hospital, Brisbane, Australia
4 Central Sydney Immunology Laboratory, Royal Prince Alfred Hospital, Sydney, Australia

Correspondence to:
Dr R C W Wong, Division of Immunology, QHPS, Princess Alexandra Hospital, Wooloongabba, QLD 4102, Australia;
richard_wong{at}health.qld.gov.au Aims: Tissue transglutaminase (tTG) is a major autoantigen recognised by IgA anti-endomysial antibodies (IgA EMA). Enzyme linked immunosorbent assays (ELISA) for IgA anti-tissue transglutaminase antibodies (IgA tTG) have therefore been developed as an alternative serological screening test to IgA EMA for coeliac disease (CD). The use of human tTG (h-tTG), as opposed to guinea pig liver tTG (gpl-tTG), in these assays has been reported to produce superior results. This study compared 13 commercial IgA tTG ELISA kits to ascertain their performance characteristics in the diagnosis of CD in patients with biopsy confirmed disease compared with controls. All patients and controls were adults aged 21 years or older.

Methods: Sera from the following groups of patients were tested in each kit: (1) 49 patients with CD confirmed on small bowel biopsies (all IgA EMA positive); (2) 34 patients with small bowel biopsies that were not consistent with CD; and (3) 30 patients with biopsy confirmed inflammatory bowel disease. All controls were negative for IgA EMA and were not IgA deficient. Sensitivities and specificities were determined using both the manufacturers' recommended cut off points and receiver operating characteristic (ROC) analysis derived decision thresholds. The area under the curve (AUC) for each ROC plot was also calculated and compared between kits.

Results: In general, the h-tTG based IgA tTG ELISA kits demonstrated superior performance (especially specificity) compared with the gpl-tTG based kits, although 100% sensitivity and specificity (comparable to the IgA EMA assay) was obtained in only one recombinant h-tTG based kit.

Conclusions: The use of h-tTG in IgA tTG ELISA kits is generally, but not universally, associated with superior performance. Factors other than antigen source are important in determining kit performance.


Keywords: coeliac disease; guinea pig liver; human; tissue transglutaminase

Abbreviations: ABTS, 2.2`-azino-bis-3-ethylbenzthiazolin-6-sulphonic acid; AU, arbitrary units; AUC, area under curve; BSA, bovine serum albumin; CD, coeliac disease; ELISA, enzyme linked immunosorbent assay; gpl-tTG, guinea pig liver tissue transglutaminase; HRP, horseradish peroxidase; h-tTG, human tissue transglutaminase; IBD, inflammatory bowel disease; IgA EMA, IgA anti-endomysial antibody; IgA tTG, IgA anti-tissue transglutaminase antibody; IIF, indirect immunofluorescence; PNPP, paranitrophenyl phosphate; ROC, receiver operating characteristic; TMB, 3,3`,5,5` tetramethylbenzidine; tTG, tissue transglutaminase




This article has been cited by other articles:


Home page
Arch. Dis. Child.Home page
A F Rodrigues and H R Jenkins
Investigation and management of coeliac disease
Arch. Dis. Child., March 1, 2008; 93(3): 251 - 254.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. H.R. Green and C. Cellier
Celiac Disease
N. Engl. J. Med., October 25, 2007; 357(17): 1731 - 1743.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
M. Hadithi, B. M. E. von Blomberg, J. B. A. Crusius, E. Bloemena, P. J. Kostense, J. W.R. Meijer, C. J.J. Mulder, C. D.A. Stehouwer, and A. S. Pena
Accuracy of Serologic Tests and HLA-DQ Typing for Diagnosing Celiac Disease
Ann Intern Med, September 4, 2007; 147(5): 294 - 302.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M Esteve, M Rosinach, F Fernandez-Banares, C Farre, A Salas, M Alsina, P Vilar, A Abad-Lacruz, M Forne, M Marine, et al.
Spectrum of gluten-sensitive enteropathy in first-degree relatives of patients with coeliac disease: clinical relevance of lymphocytic enteritis
Gut, December 1, 2006; 55(12): 1739 - 1745.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
A. Diamanti, F. Colistro, A. Calce, R. Devito, F. Ferretti, A. Minozzi, A. Santoni, and M. Castro
Clinical Value of Immunoglobulin A Antitransglutaminase Assay in the Diagnosis of Celiac Disease
Pediatrics, December 1, 2006; 118(6): e1696 - e1700.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
D A van Heel and J West
Recent advances in coeliac disease
Gut, July 1, 2006; 55(7): 1037 - 1046.
[Full Text] [PDF]


Home page
CVIHome page
E. Zintzaras and A. E. Germenis
Performance of Antibodies against Tissue Transglutaminase for the Diagnosis of Celiac Disease: Meta-Analysis
Clin. Vaccine Immunol., February 1, 2006; 13(2): 187 - 192.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Doolan, K. Donaghue, J. Fairchild, M. Wong, and A. J. Williams
Use of HLA Typing in Diagnosing Celiac Disease in Patients With Type 1 Diabetes
Diabetes Care, April 1, 2005; 28(4): 806 - 809.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
A. Alaedini and P. H.R. Green
Narrative Review: Celiac Disease: Understanding a Complex Autoimmune Disorder
Ann Intern Med, February 15, 2005; 142(4): 289 - 298.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
I. Dahlbom, M. Olsson, N. K. Forooz, A. G. Sjoholm, L. Truedsson, and T. Hansson
Immunoglobulin G (IgG) Anti-Tissue Transglutaminase Antibodies Used as Markers for IgA-Deficient Celiac Disease Patients
Clin. Vaccine Immunol., February 1, 2005; 12(2): 254 - 258.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
B. Van Meensel, M. Hiele, I. Hoffman, S. Vermeire, P. Rutgeerts, K. Geboes, and X. Bossuyt
Diagnostic Accuracy of Ten Second-Generation (Human) Tissue Transglutaminase Antibody Assays in Celiac Disease
Clin. Chem., November 1, 2004; 50(11): 2125 - 2135.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.